Novo Nordisk’s head of commercial strategy steps down
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) – Novo Nordisk’s head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday. Novo’s rare disease unit head, Ludovic Helfgott, who was already on the executive management team, will immediately assume the responsibility for product and …
Novo Nordisk’s head of commercial strategy steps down Read More »










